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Abstract
Background:  Malaria in pregnancy is associated with immunological abnormalities in the
newborns, such as hampered T-helper 1 responses and increased T-regulatory responses, while
the effect of maternal Plasmodium falciparum infection on foetal innate immunity is still
controversial.
Materials and methods: The immunophenotype and cytokine release by dendritic cells (DC)
and monocytes were evaluated in cord blood from 59 Beninese women with or without malaria
infection by using flow cytometry.
Results: Accumulation of malaria pigment in placenta was associated with a partial maturation of
cord blood myeloid and plasmacytoid DC, as reflected by an up-regulated expression of the major
histocompatibility complex class II molecules, but not CD86 molecules. Cells of newborns of
mothers with malaria pigment in their placenta also exhibited significantly increased cytokine
responses upon TLR9 stimulation. In addition, maternal age and parity influenced the absolute
numbers and activation status of cord blood antigen-presenting cells. Lastly, maternal age, but not
parity, influenced TLR3, 4 and 9 responses in cord blood cells.
Discussion:  Our findings support the view that placental parasitization, as indicated by the
presence of malaria pigment in placental leukocytes, is significantly associated with partial
maturation of different DC subsets and also to slightly increased responses to TLR9 ligand in cord
blood. Additionally, other factors, such as maternal age and parity should be taken into
consideration when analysing foetal/neonatal innate immune responses.
Conclusion: These data advocate a possible mechanism by which PAM may modulate foetal/
neonatal innate immunity.
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Background
Pregnancy-associated  Plasmodium falciparum malaria
(PAM) results, sometimes, in massive intervillous inflam-
mation that contributes to placental insufficiency,
impaired intra-uterine growth and consequently to low
birth weight in the newborns and a higher risk of dying
early in life [1-4].
Infants born to women with PAM are more predisposed to
P. falciparum infection in their first year of life [5-7].
Immunological mechanisms are generally considered to
play an important role in causing this susceptibility. In
utero sensitization to transplacentally transferred soluble
P. falciparum antigens may constitute the basis for
increased susceptibility to malaria episodes in early life.
Importantly, it has been demonstrated that cord blood
mononuclear cells (CBMC) of neonates born to mother
with PAM specifically respond to plasmodial asexual stage
antigens, and that cord blood B cells produce anti-malaria
specific IgM and IgE antibodies [5,8-10], providing irrefu-
table evidence of in utero sensitization.
In this context, active infection in the placenta by P. falci-
parum was associated with hampered T-helper 1 (Th1)
responses, as reflected by reduced IFN-γ production upon
T-cell stimulation [9]. In addition, the anti-inflammatory
IL-10 cytokine is more frequently produced by CBMC of
those born to mothers with PAM compared with non-
infected mothers [11]. CD4+CD25high regulatory T-cells
(Treg) are a principal source of IL-10 in such cases [12].
Treg are found at higher frequency in cord blood (CB) of
neonates born to mothers with PAM at delivery as com-
pared to unexposed newborns [12].
Because of their key function in the initiation and regula-
tion of adaptive immune responses, it is reasonable to
assume that antigen presenting cells (APC), such as
monocytes and dendritic cells (DC), contribute to the
modulation of foetal immune responses upon exposure
to  P. falciparum in utero. Indeed, DC seem to play an
important role in both protective and dysfunctional
immune responses against malaria in murine models
[13,14]. DC comprise a heterogeneous population of
cells; myeloid DC (MDC) that orchestrate T-cell responses
through a fine modulation of IL-12 secretion, while plas-
macytoid DC (PDC) are an essential component of innate
and adaptive immunity through secretion of type I inter-
ferons (IFN) in response to pathogens [15]. A minor
blood MDC population, blood DC antigen (BDCA)-3+
cells, has been described sharing the same ontogeny as the
more frequent BDCA-1+ MDC subset [16,17].
The foetal/neonatal immune system exhibits quantitative
and functional differences from the adult one and neona-
tal DC have reduced ability in delivering co-stimulatory
signals to T-cells as a consequence of their incomplete
maturation [18]. They also exhibit a markedly decreased
capacity in secreting IL-12 and IFN-α [19,20]. This proba-
bly contributes to the development and relative predomi-
nance of Treg in CB [21], although seemingly less marked
in Africans vs. Europeans [22].
Whether and how P. falciparum infection in the mother
may affect foetal innate immunity is poorly understood.
One study conducted in The Gambia reported lower
lipopolysaccharide (LPS)-induced IFN-γ and IL-12 activity
in CBMC of newborns of mothers with PAM as compared
to uninfected mothers [9]. A more recent study revealed
that CBMC of neonates born of Gabonese mothers with P.
falciparum infection exhibit significantly increased IFN-γ
responses upon stimulation with toll-like receptor (TLR)3
and TLR4 ligands [22].
Contrasting findings have also been reported on the char-
acterization of DC subsets in CBMC of neonates born to
P. falciparum-infected mothers. One study reported a sig-
nificantly higher frequency of MDC [23], while another
reported profoundly reduced numbers of PDC [24] as
compared to unexposed newborns.
The mechanistic hypothesis behind the present study is
that malaria infection in the mother may cause a dysfunc-
tional activation of foetal APC by parasite-derived prod-
ucts that cross the placenta. An altered activation of foetal
APC could be responsible for the impaired T-cell response
that is observed in infants born to mothers with PAM.
Using flow cytometry, subpopulations of DC and mono-
cytes were evaluated in CB of neonates from Beninese
women with or without malaria infection. In addition,
the impact of P. falciparum exposure in utero, on the innate
activation of foetal APC was examined by stimulating
CBMC with specific TLR ligands; LPS was employed to
activate TLR4 on monocytes and BDCA-1+MDC, polyino-
sine-polycytidilic acid (PolyI:C) to selectively stimulate
TLR3 expressed in MDC, and CpG-A ODN to specifically
activate TLR9 expressed in PDC [16,17,25].
Methods
Study population
Pregnant women were enrolled after informed consent
from July 2006 to January 2007; in the Hospital "Mother
and Child Lagune", the main obstetrical referring hospital
in Cotonou. This study was approved by the Science and
Health Faculty Ethics Committee. To identify women with
malaria infection, a rapid immuno-chromatographic test
(Cypress®, Langdorp, Belgium) was performed on finger-
pricked capillary blood before delivery. Thirty P. falci-
parum-infected women and twenty-nine uninfected
women matched for parity and age were enrolled in the
study. Twenty-five ml heparinized CB were collected
immediately after delivery. According to national policy,Malaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
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pregnant women receive intermittent preventive treat-
ment with sulphadoxine-pyrimethamine (SP). Despite
this usage of SP was declared by only 47% of the women,
while the remaining mothers declared having taken chlo-
roquine (CQ) as chemoprophylaxis.
Determination of P. falciparum status of the mothers at 
delivery
Thin and thick smears were prepared from maternal
peripheral, placental intervillous and cord blood, stained
with Giemsa and examined for the presence and density
of parasites. Malaria infection in the mothers at delivery
was defined by the presence of parasites in the placental
and/or maternal peripheral blood. The presence of
malaria pigment (MP) was also evaluated in leukocytes of
placental intervillous blood (Table 1).
CBMC cultures
Mononuclear cells were isolated from CB by centrifuga-
tion over Ficoll-Hypaque (Pharmacia Uppsala, Sweden).
Cells were washed twice and resuspended in RPMI 1640
medium with L-glutamine (Gibco Eragny, France) supple-
mented with 10% foetal bovine serum (FBS, Gibco) and
50 μg/ml gentamycin to a final concentration of 2 × 106
CBMC/ml. Viability was > 99% in all tested samples as
determined by Trypan blue staining.
To assess production of IL-12, CBMC were stimulated for
8 hours with LPS (100 ng/ml; Sigma Aldrich, St. Louis
MO), PolyI:C (20 μg/ml; Sigma Aldrich), or synthetic
haemozoin (Hz, 5 μg/ml) in the presence of Brefeldin-A
(BD Pharmingen, San Diego, CA) during the last five
hours of incubation. Hz was prepared from haemin chlo-
ride as described [26]. Endotoxin levels in the Hz prepara-
tion were found to be below the threshold (<0.125 units/
ml) by the Limulus-amoebocyte lysate assay (Biowhit-
taker, Cambrex). To assess cytokine production by CBMC
upon contact with TLR9 ligands, CpG-A ODN 2216 (3 μg/
ml; Metabion GmbH, Martinsried, Germany) was
employed.
Immunophenotype of APC
CBMC were resuspended in staining buffer (PBS 2% FBS,
5 mM EDTA). Cells were first incubated with FcR blocking
reagent (Miltenyi Biotech, Bergisch-Gladbach, Germany)
and then with anti-CD14-FITC, anti-CD19-FITC, anti-
BDCA-1-PE, anti-BDCA-2-PE, anti-BDCA-3-PE (Miltenyi
Biotech), anti-HLA-DR-PerCP and anti-CD86-APC (BD
Pharmingen), or alternatively mouse isotype controls (BD
Pharmingen). Cell acquisition was performed with a FAC-
SCalibur flow cytometer (BD Pharmingen) and analysis
was performed by CellQuest software as described in Fig-
ure 1A.
Intracellular cytokine staining for IL-12
After stimulation, cells were incubated with FcR blocking
reagent and stained with anti-HLA-DR-PerCP, anti-CD14-
FITC, anti-CD19-FITC, anti-BDCA-1-PE, anti-BDCA-3-PE
or isotype controls for 10 min at 4°C. Cells were then
fixed with FACS lysing solution, washed and incubated in
a permeabilization buffer (staining buffer with 0.25%
saponin and 5% AB human serum) for 15 min at 4°C.
After centrifugation, cells were stained with anti-IL-12-
APC (BD Pharmingen) or alternatively APC-conjugated
Table 1: Summary of the study population.
Study group
Characteristics P. falciparum-positive P. falciparum-negative
Number of subjects n = 59 30 29
Age of mother, mean ± SD, years 25.4 ± 6.1 26.3 ± 5.2
Pregnancies, no., mean ± SD 2.2 ± 1.5 2.1 ± 1.1
1-2 pregnancies (n = 41) 21 20
≥ 3 pregnancies (n = 18) 9 9
Ratio of malaria prevention (CQ/SPa) (30/27) 19/10 11/17
Declaration of malaria infection during pregnancy (%) 33.3 3.7
Reported use of bednet (%) 83.3 82.8
Neonate birth weight, mean ± SD, g 3052.8 ± 443.3 3059.6 ± 412.5
Neonate gender, female/male (21/34) 10/19 11/15
P. falciparum density at delivery:
peripheral blood, mean ± SD, iRBCb/μl 19,037 ± 55,257 0
intervillous blood, mean ± SD, iRBC/μl 245,764 ± 475,906 0
cord blood, mean ± SD, iRBC/μl0 0
intervillous blood leukocytes with MPc, n = 59 19 0
a CQ/SP; Chloroquine/sulfadoxine-pyrimethamine
b iRBC; infected red blood cells
c MP; malaria pigmentMalaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
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(A) Flow cytometric identification of MDC (BDCA-1+ or BDCA-3+) and PDC (BDCA-2+) in CBMC from one subject Figure 1
(A) Flow cytometric identification of MDC (BDCA-1+ or BDCA-3+) and PDC (BDCA-2+) in CBMC from one 
subject. R1 gate was set to include only viable mononuclear cells, as determined by forward scatter (FSC) and side-scatter 
(SSC) characteristics. Furthermore, cells were gated to be both CD14 and CD19 negative (R2) and either BDCA-1, BDCA-3, 
or BDCA-2 positive (R3). One million events were analysed for DC, 300,000 events for monocytes and 100,000 events for iso-
type control enumeration. The percentages represent relative levels of the different DC populations from the selected subject. 
(B) Partial activation of cord blood BDCA-1+ and BDCA-2+ cells is related to the presence of MP in placenta. The expression 
levels of HLA-DR and CD86 were measured by flow cytometry on foetal APC subsets from 16 MP-positive (diagonal striped 
bars) and 39 MP-negative mothers (white bars). Boxplots illustrate the medians and the 25th and 75th percentiles. Y-axes report 
percentage of positive cells and mean fluorescence intensity (MFI) for the activation markers CD86 and HLA-DR in different 
APC subsets. P-values were calculated by Mann-Whitney U test. The significance limit was P < 0.05.Malaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
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isotype control for 30 min at 4°C, and then analysed by
flow cytometry. BDCA-1+ and BDCA-3+ cells that did not
express CD19 and CD14 were gated together as MDC.
Determination of cytokine levels in plasma samples and 
supernatants
IFN-α levels were measured with an ELISA kit (PBL Bio-
medical Laboratories, Piscataway, NJ). The assay sensitiv-
ity was 12.5 pg/ml. A panel of pro-inflammatory and anti-
inflammatory cytokines including IL-6, IL-10, IL-12,
(MIP)-1α/CCL3; TNF-α and IFN-γ were quantified by the
Human Cytokine Cytometric Bead Array Kit (BD
Pharmingen) using flow cytometry. The assay sensitivity
was 1.6 pg/ml; 0.13 pg/ml; 0.6 pg/ml; 0.2 pg/ml; 1.2 pg/
ml; and 1.8 pg/ml for IL-6, IL-10, IL-12, MIP-1-α/CCL3,
TNF-α and IFN-γ respectively. Results were formatted
using the BD CBA Analysis Software.
Statistical analysis
Background values on cytokines in supernatants obtained
from unstimulated cells were subtracted from data
acquired from cultures in the presence of stimuli. Nor-
mally distributed variables were analysed by unpaired t
test. Data that were not normally distributed even after
log-transformation were analysed by the non-parametric
Mann-Whitney test. To test if the age of the mother was
related to parity, Spearman rank correlation was
employed. Linear regression analysis on log-transformed
data was used to identify dependent variables for a multi-
variate analysis. The significance limit was P < 0.05.
Results
Partial activation of foetal DC is related to the presence of 
MP in placenta
The absolute numbers of APC subpopulations and expres-
sion of activation markers are described in Table 2. CBMC
contained MDC at a higher frequency than PDC, resulting
in a mean BDCA-1+/BDCA-2+ cell ratio of 4.4 ± 5.2.
Segregation on the basis of maternal malaria infection
(i.e. presence of parasites in placental and/or maternal
peripheral blood) did not show differences either in the
absolute number of foetal APC or in the expression levels
of MHC class II and CD86 molecules in different APC
subsets studied (additional file 1). However, foetal APC
status segregated on the basis of presence or absence of
MP in the placenta, revealed a significant up-regulation of
the MHC-class II expression, but not of CD86, on BDCA-
1+ and BDCA-2+ DC in CB obtained from MP-positive
mothers as compared to MP-negative mothers (Figure
1B). Thus, a partial activation of foetal DC is related to the
presence of MP in the placenta, and not to maternal infec-
tion at delivery.
Impact of age and parity of the mother on the frequency 
and activation status of foetal APC
The absolute numbers of monocytes and BDCA-1+ MDC
in CB were negatively associated with maternal age and
parity (Figure 2A and 2B). In addition, maternal age
showed a positive correlation with higher expression lev-
els of CD86 on monocytes (Figure 2A). We also observed
significantly increased MHC-class II expression on BDCA-
2+ DC in CB from multigravidae as compared to mothers
undergoing first or second pregnancy (Figure 2B).
As expected, maternal age and multiparity were related
(Spearman coefficient = 0.47; P = 0.0002). The multivari-
ate analysis showed an effect of both age and parity on CB
monocytes and BDCA-1+ cells absolute numbers (age: β =
+0,55 (0,10-1,00) with P = 0,02 and parity: β = +0,42 (-
0,06-0,90) with P = 0,08).
Malaria status of the mother does not affect 
immunophenotype of foetal APC upon TLR and Hz 
stimulation
By examining MHC class II expression, CB monocytes and
MDC were activated by LPS and PolyI:C stimulation
Table 2: APC absolute numbers and immunophenotype in cord blood samples.
APC subset
Parameter: median (± interquartile) Monocytes MDC PDC
CD14+ BDCA-1+ BDCA-3+ BDCA-2+
% of total CBMC 13.00 ± (7.10) 0.62 ± (0.42) 0.19 ± (0.18) 0.25 ± (0.18)
absolute no./ml 624,787 ± (571,630) 23,850 ± (30,430) 8,160 ± (12,225) 9,680 ± (9,032)
% HLA-DR+ cells 93.87 ± (7.09) 93.53 ± (11.01) 59.95 ± (28.55) 82.64 ± (31.69)
HLA-DR, MFIa 132.71 ± (17.69) 162.50 ± (18.81) 118.26 ± (40.81) 129.9 ± (39.59)
% CD86+ cells 50.28 ± (34.37) 44.67 ± (22.15) 35.95 ± (20.98) 18.47 ± (13.41)
CD86, MFI 62.36 ± (30.17) 57.51 ± (21.12) 45.54 ± (17.80) 33.29 ± (13.77)
Immunophenotyping was performed on 55 cord blood samples; 27 from malaria infected women and 28 from uninfected women. APC were 
quantified as a percentage of the total CBMC. Absolute numbers of MDC, PDC and monocytes were calculated from CBMC counts. HLA-DR and 
CD86 expression levels were then examined in different APC subsets.
a; MFI, mean fluorescence intensityMalaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
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(Table 3). In addition, when we added synthetic Hz as
stimulus, we found monocytic activation, as shown by
significantly increased expression levels of MHC class II
molecules, while the MHC class II levels on MDC were
not affected (Table 3). However, there was no difference
in MHC class II expression following stimulation with
TLR3 and TLR4 ligands or synthetic Hz on CB monocytes
and MDC when segregated according to the presence of
MP in the placentas (Table 3). Thus, MP positivity did not
affect further phenotypic ex- vivo maturation of foetal APC
by diverse TLR ligands or Hz.
Plasmodium falciparum infection in the mother induces 
amplification of TLR9 response in foetal leukocytes
Cytokine secretion in APC is triggered by the recognition
of microbial pathogens through TLR [15]. The ability of
foetal APC to secrete cytokines by stimulating CBMC with
different TLR ligands was investigated. IFN-α was evalu-
ated in supernatants of unstimulated, CpG-A- and Hz-
stimulated CBMC cultures. As previously reported
[19,27], unstimulated and synthetic Hz-stimulated CBMC
did not secrete any IFN-α, while CpG-A-stimulated cells,
most likely PDC, produced low levels of this cytokine
(0.12 ± 13.79 pg/ml; median ± interquartile). No differ-
ence was observed in IFN-α production upon CpG-A stim-
ulation when CBMC were segregated according to
accumulation of MP in placenta: (0.01 ± 12.04 pg/ml vs
1.90 ± 18.21 pg/ml; MP-negative vs MP-positive women;
p = 0.45).
The levels of IL-6, IL-10, IL-12, MIP-1α/CCL3α IFN-γ and
TNF-α were also quantified in supernatants of CBMC that
were either unstimulated or stimulated with synthetic Hz
or different TLR ligands. TLR3, TLR4 and, to a lesser
extent, TLR9 stimulation induced release of both pro- and
anti-inflammatory cytokines (Figure 3). The presence of
MP in the placenta influenced TLR-mediated CBMC
cytokine responses such that the production of IL-10 and
TNF-α was significantly higher upon TLR9 stimulation
and there was a similar trend for increased production of
IFN-γ after TLR-3 stimulation in CBMC of neonates of
mothers with MP-positive placenta as compared to MP-
negative mothers (Figure 3).
To further analyse the production of IL-12 by different
APC subsets upon TLR3 and TLR4 stimulation, we per-
formed intracellular cytokine staining. Only a minor pop-
ulation of foetal APC produced IL-12. In fact, 2.7% ± 3.4%
and 2.6% ± 3.8% of IL-12-producing monocytes (median
± interquartile) were observed in response to LPS and
PolyI:C, respectively, and 2.7% ± 3.5% and 2.0% ± 3.6%
of IL-12-producing MDC (median ± interquartile) were
found in responses to LPS and PolyI:C, respectively. How-
ever, no differences were observed when comparing foetal
APC of mothers with or without MP accumulation in pla-
centa (table 4).
Fifty-seven plasma samples from CB of mothers were ana-
lysed for cytokine levels. In all samples we found detecta-
Association between APC numbers and activation and  maternal age or parity Figure 2
Association between APC numbers and activation 
and maternal age or parity. (A) Data were segregated 
into 2 groups according to the median value for maternal age. 
Absolute numbers and CD86 expression levels (as percent-
age of positive cells and mean fluorescence intensity, MFI) on 
different foetal APC subsets were analysed as a function of 
maternal age in 31 women ≤ 25 years of age and 24 women > 
25 years of age Boxplots illustrate the medians and the 25th 
and 75th percentiles. (B) Women were divided for parity as 
paucigravidae (1st and 2nd pregnancy) and multigravidae (≥ 3 
pregnancies) as we previously observed that women at first 
and second pregnancy exhibited the same risk of malaria 
infection (Fievet, unpublished data). Absolute numbers and 
HLA-DR expression levels (as percentage of positive cells 
and mean fluorescence intensity, MFI) on different foetal 
APC subsets were analysed as a function of parity in 37 
women undergoing first or second pregnancy and 18 multi-
gravidae. Boxplots illustrate the medians and percentiles. P-
values were calculated by Mann-Whitney U test. The signifi-
cance limit was P < 0.05.Malaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
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ble levels of IFN-α, IL-6, IL-10, IL-12, MIP-1-α/CCL3 and
TFN-γ but no IFN-γ. The CB plasma levels of the different
cytokines were not influenced by the presence of malaria
infection in the mother (Figure 4A) or by MP accumula-
tion in placenta (Figure 4B).
Thus, cytokine responses to TLR3, 4 and 9 ligands and to
Hz were observed, with amplification of TLR9-mediated
responses in CBMC from MP-positive mothers.
Maternal age influences TLR3, 4 and 9 responses of foetal 
leukocytes and cytokine levels in foetal plasma
Segregation of samples into two groups according to the
median value for maternal age revealed significant differ-
ences in cytokine production after TLR3, 4 and 9 stimula-
tion of CBMC. The levels of TNF-α, IFN-γ, MIP-1α/CCL3
and IL-10 produced in response to LPS by CBMC of new-
borns of mothers ≤ 25 years were significantly higher than
those produced by CBMC of neonates born to mothers >
25 years. In addition, the amount of TNF-γ and IL-10 pro-
duced by CBMC in response to TLR3 and TLR9 ligands
were negatively associated with maternal age (Figure 5).
Parity had no influence on cytokine secretion by CBMC
upon TLR stimulation (Figure 6).
Significant differences were also observed in CB cytokine
levels according to maternal age. Foetal plasma from
mothers > 25 years of age exhibited significant lower lev-
els of IL-10 as compared to younger mothers (Figure 4C).
Thus, productions of cytokines by CBMC and plasma lev-
els for IL-10 were higher in children born to the younger
mothers.
When an effect of both MP-positivity in placenta and
maternal age on cytokines in supernatants was observed,
the multivariate analysis showed that maternal age was
predominant and that effect of MP-positivity disappeared
for IL-10 in response to TLR9 ligands (β = 1.23 (0.56-
1.89) P = 0.001). However, both MP-positivity and mater-
nal age had an effect on TNF-α secretion upon TLR9 stim-
ulation (MP: β = 0.88 (0.024-1.74), P = 0.04; Age: β = 1.04
(0.23-1,74), P = 0.04).
Discussion
The consensus view is that in utero sensitization to P. falci-
parum antigens is a common phenomenon during PAM.
Parasites do not usually cross the placental barrier and
such sensitization is most probably caused by the trans-
placental passage of soluble P. falciparum antigens [8,28].
Accordingly, no parasite-positive smears were detected in
CB samples of malaria-infected women in this study pop-
ulation.
Pregnant women declared to receive either SP or CQ as
malaria prevention during pregnancy. In contrast to a pre-
vious study performed in the same area [29], no differ-
ences were observed for P. falciparum infection rate
according to the type of prophylaxis used by the mothers.
However, the number of subject included in this study
was low and the project was not designed to examine this
matter.
In this study, the foetal BDCA-1+ and BDCA-2+ DC subsets
expressed significantly higher levels of MHC class II mol-
ecules upon PAM, as indicated by the presence of P. falci-
parum  MP in placenta, which is in agreement with
Table 3: Immunophenotype of fetal APC upon TLR and Hz stimulation.
Monocytes MDC
Parameter
median 
(± interquartile)
stimulus Total CB MP-Negative MP-Positive Total CB MP -Negative MP-Positive
% HLA-DR+ cells unstimulated 89.34 ± (13.90) 89.33 ± (16.57) 89.79 ± (7.27) 88.78 ± (19.83) 87.33.40 ± (19.83) 92.62 ± (20.13)
Hz 91.03 ± (10.10) 90.46 ± (11.97) 92.27 ± (8.31) 90.99 ± (12.22) 89.40 ± (13.55) 91.37 ± (7.88)
LPS 96.73 ± (6.22) 96.73 ± (7.61) 96.45 ± (3.14) 93.24 ± (11.08) 93.24 ± (11.66) 93.38 ± (15.23)
Poly I:C 96.79 ± (4.68) 96.79 ± (7.99) 96.70 ± (2.27) 93.99 ± (12.57) 93.08 ± (9.54) 92.09 ± (16.42)
HLA-DR, MFIa unstimulated 120.81 ± (20.14) 121.15 ± (24.36) 119.54 ± (16.48) 143.85 ± (23.19) 143.57 ± (21.28) 149.29 ± (22.77)
Hz 122.08 ± (20.42) 
*
125.36 ± (23.00) 121.47 ± (15.15) 146.96 ± (14.93) 151.30 ± (14.69) 156.06 ± (20.47)
LPS 135.72 ± (16.78)* 137.56 ± (18.02) 133.23 ± (13.82) 152.40 ± (16.28)* 145.49 ± (19.31) 150.67 ± (13.84)
Poly I:C 136.53 ± (15.66)* 137.27 ± (19.29) 136.41 ± (13.51) 150.16 ± (14.93)* 150.61 ± (16.72) 149.60 ± (16.35)
Immunophenotyping on stimulated cells was performed on 43 cord blood samples (total CB); 12 from women with MP accumulation in placenta (MP-
Positive) and 31 without MP in placenta (MP-negative). All comparison between MP-Negative and MP-Positive were not significant.
a; MFI, mean fluorescence intensity
*; P < 0.05Malaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
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previous data [23]. The observation that CD86 expression
on foetal DC was unaffected by PAM suggests that P. falci-
parum stimulation in utero induces only partial activation
of these cells. Failure to provide DC with a sufficiently
strong costimulatory signals can impair the ability to form
stable interactions with T-cells, as recently shown in a
murine model of malaria [30]. Partial DC maturation can
lead to altered T-cell activation and induction of tolerance
[31-34], possibly contributing to impaired immune
responses that have been observed in the offspring of
mothers with PAM [9,11].
The findings presented in this study diverge from those of
studies on peripheral blood DC from children with acute
malaria, where expression levels of MHC class II on the
BDCA-1+ DC are reduced compared to healthy controls
[35,36]. Also, no increase in foetal BDCA-3+ DC was
detected upon maternal malaria infection in this study
like others have shown in children with severe malaria
[35]. Circulating APC are continuously exposed to P. falci-
parum-infected erythrocytes during malaria episodes in
children, which may exert a contact-mediated inhibitory
effect on DC functionality, as demonstrated by in vitro
studies [4,37]. Conversely, infected erythrocytes are rarely
detected in CB of those born to mothers with PAM
[23,38]. Thus, foetal APC would rarely if ever encounter
parasitized red-blood cells, but would be primarily
exposed to and influenced by parasite-derived soluble
compounds.
Interestingly, TLR9 stimulation led to increased pro- and
anti-inflammatory responses of CBMC of neonates whose
mothers had MP accumulating in placentas, and there was
a tendency towards increased IFN-γ response upon TLR3
stimulation in the same group. Responses via other TLR
ligands, such as LPS were amplified in CBMC but did not
change appreciably as a function of maternal malaria
infection. Thus, foetal different TLR responses are inde-
pendently modulated by in utero exposure to P. falciparum,
consistent with a recent study [22].
In humans only PDC and B cells express TLR9 [39]. In this
study, CpG-A, a TLR9 ligand that specifically stimulates
TLR-induced cytokine responses in CBMC obtained from  women with or without MP accumulation in placenta Figure 3
TLR-induced cytokine responses in CBMC obtained 
from women with or without MP accumulation in 
placenta. CBMC (2 million/ml) were stimulated or not with 
synthetic Hz (5 μg/ml), LPS (100 ng/ml), CpG-A (3 μg/ml) or 
PolyI:C (20 μg/ml). After 18 hours, supernatants were col-
lected and analysed for IL-6, IL-10, IL-12, IFN-α, TNF-α and 
MIP-1α/CCL3 levels. Data represent median values and per-
centiles for 59 individuals; 16 MP-positive (diagonal striped 
bars) and 43 MP-negative mothers (white bars). Cytokine 
levels in unstimulated cells were subtracted from the values 
shown. P-values were calculated by Mann-Whitney U test or 
t test (see Subjects, Materials and Methods). The significance 
limit was P < 0.05.
Table 4: Accumulation of MP in placenta does not affect IL-12 production by APC upon TLR3 and TLR4 stimulation.
Monocytes MDC
Parameter
median (± interquartile)
stimulus MP-Negative MP-Positive MP-Negative MP-Positive
IL-12 (% positive cells) LPS 3.55 ± (4.13) 2.70 ± (3.15) 3.13 ± (3.72) 2.13 ± (1.72)
Poly:IC 2.33 ± (3.37) 3.99 ± (4.49) 1.95 ± (4.01) 2.38 ± (3.09)
Intracytoplasmic IL-12 production by APC upon TLR3 and TLR4 stimulation was analysed on 43 cord blood samples; 31 from MP-negative women 
and 12 MP-positive women. All comparisons between MP-negative and MP-positive women were not significant.Malaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
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PDC [25,40], was employed. In concordance with the
findings presented in this study, MP or alternatively plas-
modial DNA bound to MP activate the TLR9 pathway in
human and murine PDC [27,41,42]. This would suggest a
role for MP derived from maternal parasitic infection in
inducing foetal BDCA-2+  DC partial maturation and
increased sensitization to TLR9 ligands. Nevertheless,
only low levels of IL-10 and TNF-α were detected in
CBMC cultures upon TLR9 stimulation. This was not
unexpected given the low frequency of cells able to specif-
ically respond to such stimulus. The biological signifi-
cance of a slightly increased release of IL-10 and TNF-α by
CBMC upon TLR9 stimulation after in utero exposure to P.
falciparum is uncertain.
Cord blood cytokine levels are affected by maternal age, but  not by maternal P. falciparum infection or MP accumulation  in placenta Figure 4
Cord blood cytokine levels are affected by maternal 
age, but not by maternal P. falciparum infection or 
MP accumulation in placenta. Foetal plasma samples 
were collected at delivery and subsequently analysed for IL-6, 
IL-10, IL-12, IFN-γ, TNF-α and MIP-1α/CCL3 levels. (A) Data 
represent median values and percentiles for 57 individuals 
divided in 27 P. falciparum negative mothers (Pf-negative, 
white bars) and 30 P. falciparum positive mothers (Pf-positive, 
diagonal striped bars). (B) Women were divided in 39 MP-
negative mothers (white bars) and 18 MP-positive (diagonal 
striped bars). (C) Women were divided in 33 mothers ≤ 25 
years of age (white bars) and 24 women > 25 years (diagonal 
striped bars) Values were calculated by Mann-Whitney U test 
or t test (see Subjects, Materials and Methods). The signifi-
cance limit was P < 0.05.
TLR-induced cytokine responses in foetal leukocytes are  influenced by maternal age Figure 5
TLR-induced cytokine responses in foetal leukocytes 
are influenced by maternal age. CBMC (2 million/ml) 
were stimulated with synthetic Hz (5 μg/ml), LPS (100 ng/ml), 
CpG-A (3 μg/ml) or PolyI:C (20 μg/ml). After 18 hours, 
supernatants were collected and analysed for IL-6, IL-10, IL-
12, IFN-α, TNF-α and MIP-1α/CCL3 levels. Cytokine levels 
in unstimulated cells were subtracted from the values shown. 
P-values were calculated by Mann-Whitney U test or t test 
(see Subjects, Materials and Methods). The significance limit 
was P < 0.05. Data represent median values and percentiles 
for 57 individuals; 33 mothers ≤ 25 years of age (white bars) 
and 24 women > 25 years (diagonal striped bars) (Data on 
maternal age were missing for 2 subjects, that were there-
fore not included in this analysis).Malaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
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Notably, MP was the only indicator of maternal malaria
infection that was significantly associated with partial
activation of foetal DC and to amplified innate response
to TLR9 ligation, while other markers of maternal parasit-
ization at delivery such as the presence of parasites in
peripheral and/or placental blood, were unrelated to DC
activation in the exposed newborns. It has been recently
postulated that accumulation of MP in leukocytes is a
good indicator of total parasite burden, including parasite
sequestration [43], and therefore we can consider accu-
mulation of MP in placenta as a marker of high intensity
of maternal malaria infection and/or of prolonged para-
site exposure. In addition, accumulation of MP in placen-
tal leukocytes has been associated with increased
monocyte activation and inflammation [44]. As a hypoth-
esis, accumulation of MP may represent a specific activa-
tion stimulus and inflammation at the placental level and
this may cause partial and inadequate activation of APC in
the foetal compartment.
Additionally, maternal age and parity should be taken
into consideration when analysing foetal/neonatal innate
immunity. Women of higher parity and increased age
delivered babies in whom significantly fewer blood APC
were found, but these cells exhibited an enhanced activa-
tion status. Maternal age but not parity also influenced the
APC cytokine responses upon TLR stimulation, such that
CBMC of offspring of younger mothers exhibited an
increased ability to respond to TLR3, 4 and 9 ligands.
These data are in agreement with published data on Afri-
can [23] and Caucasian [45] women and suggest that
maternal age and obstetric history may influence foetal/
neonatal immune parameters.
Consequences of increased maternal age and/or multiple
parities in terms of neonatal responses to pathogens are
poorly understood. Two recent studies indicate that the
frequency of malaria episodes is higher among infants of
malaria-infected multigravidae as compared to primi-
gravidae [6,7]. The intrinsic effect of multiple pregnancies
on malaria susceptibility in the offspring may be at least
partially explained by our finding of a significantly
reduced number of myeloid APC in foetal blood from
multigravidae. How maternal age or alternatively parity
can affect the number, activation status and cytokine
secretion capacity of cord blood APC is presently
unknown.
In conclusion, placental parasitization, as indicated by the
presence of MP in placental leukocytes, is significantly
associated with partial maturation of different DC subsets
and to slightly increased responses to a TLR9 ligand in
cord blood. As semi-maturation of DC leads to tolerance
[46], such partial foetal APC activation may contribute to
the altered T-cell responses often observed in newborns of
mothers with PAM [5-7].
These observations advocate a possible mechanism by
which PAM may modulate foetal/neonatal innate immu-
nity. Further evaluation of APC activation and down-
stream T-cell responses is ongoing in a large cohort of
newborns and infants from mothers with PAM to assess
the impact of altered DC activation on the neonatal cell-
mediated immunity.
As it is known that neonatal immune responses are largely
dependent on the innate branch of immunity and can be
improved through selective TLR stimulation [47,48], our
results should be considered in the development of effec-
TLR-induced cytokine responses in foetal leukocytes are not  influenced by parity Figure 6
TLR-induced cytokine responses in foetal leukocytes 
are not influenced by parity. CBMC (2 million/ml) were 
stimulated with synthetic Hz (5 μg/ml), LPS (100 ng/ml), 
CpG-A (3 μg/ml) or PolyI:C (20 μg/ml). After 18 hours, 
supernatants were collected and analysed for IL-6, IL-10, IL-
12, IFN-α, TNF-α and MIP-1α/CCL3 levels Cytokine level in 
unstimulated cells was subtracted from the values shown. P-
values were calculated by Mann-Whitney U test or t test (see 
Subjects, Materials and Methods). The significance limit was P 
< 0.05. Data represent median values and percentiles for 
Women were segregated on the basis of parity as 41 pauci-
gravidae (1st and 2nd pregnancy; white bars) and 18 multi-
gravidae (≥ 3 pregnancies; striped bars).Malaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
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tive vaccine strategies for infants living in areas where
malaria is endemic.
Conflict of interests
The authors declare that they have no competing interests.
Authors' contributions
NF: conceived the study, participated in its design and
coordination, acquired the data and contributed to data
analysis and interpretation and drafted the manuscript.
SV: participated in the design and coordination of the
study, contributed in data analysis and interpretation and
drafted the manuscript. IS: acquired the data and contrib-
uted to their analysis and interpretation. VB: contributed
in interpretation and statistical analysis of data and in crit-
ically revising the manuscript. SL: contributed in perform-
ing the immunoassays, and contributed in their
interpretation, participated in critically revising the man-
uscript. RP: participated in the design of the study, in the
analysis of the data and in critically revising the manu-
script. AM: participated in the design and coordination of
the study and in critically revising the manuscript. AH:
participated in the design of the study, in the analysis of
the data and in critically revising the manuscript. MT: par-
ticipated in the design of the study, in the analysis and
interpretation of data and in critically revising the manu-
script. PD: participated in the design and coordination of
the study and contributed to draft the manuscript. All
authors read and approved the final manuscript.
Additional material
Acknowledgements
We thank the maternity staff of Mother and Child Lagune hospital in sample 
collection for their support. We are grateful to the mothers who partici-
pated in the study. We acknowledge the IRD research unit in Cotonou, 
especially Pepin Kounou, Sebastien Dechavanne, Bertin Vianou, Martin 
Amadoudji for practical support. We are also grateful to Adrian Luty for 
scientific support. The work received financial support from the IMEA, 
NATIXIS, the French Ministry of Research (FSP REFS) and from SIDA/
SAREC (Sweden). S. Louis. was the recipient of an ANRS fellowship.
Ethical issues
Informed consent was obtained from all donors. The "Faculté des Sciences 
de la Santé" Committee of Beninese University approved this study.
References
1. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B,
Newman RD: Epidemiology and burden of malaria in preg-
nancy.  Lancet Infect Dis 2007, 7:93-104.
2. Menendez C, Ordi J, Ismail MR, Ventura PJ, Aponte JJ, Kahigwa E, Font
F, Alonso PL: The impact of placental malaria on gestational
age and birth weight.  J Infect Dis 2000, 181:1740-1745.
3. Ordi J, Ismail MR, Ventura PJ, Kahigwa E, Hirt R, Cardesa A, Alonso
PL, Menendez C: Massive chronic intervillositis of the placenta
associated with malaria infection.  Am J Surg Pathol 1998,
22:1006-1011.
4. Elliott SR, Spurck TP, Dodin JM, Maier AG, Voss TS, Yosaatmadja F,
Payne PD, McFadden GI, Cowman AF, Rogerson SJ, Schofield L,
Brown GV: Inhibition of Dendritic Cell Maturation by Malaria
Is Dose Dependent and Does Not Require Plasmodium falci-
parum Erythrocyte Membrane Protein 1.  Infect Immun 2007,
75:3621-3632.
5. Deloron P, Dubois B, Le Hesran JY, Riche D, Fievet N, Cornet M,
Ringwald P, Cot M: Isotypic analysis of maternally transmitted
Plasmodium falciparum-specific antibodies in Cameroon, and
relationship with risk of P. falciparum infection.  Clin Exp Immu-
nol 1997, 110:212-218.
6. Mutabingwa TK, Bolla MC, Li JL, Domingo GJ, Li X, Fried M, Duffy PE:
Maternal malaria and gravidity interact to modify infant sus-
ceptibility to malaria.  PLoS Med 2005, 2:e407.
7. Schwarz NG, Adegnika AA, Breitling LP, Gabor J, Agnandji ST, New-
man RD, Lell B, Issifou S, Yazdanbakhsh M, Luty AJ, Kremsner PG,
Grobusch MP: Placental malaria increases malaria risk in the
first 30 months of life.  Clin Infect Dis 2008, 47:1017-1025.
8. Fievet N, Ringwald P, Bickii J, Dubois B, Maubert B, Le Hesran JY, Cot
M, Deloron P: Malaria cellular immune responses in neonates
from Cameroon.  Parasite Immunol 1996, 18:483-490.
9. Ismaili J, Sande M van der, Holland MJ, Sambou I, Keita S, Allsopp C,
Ota MO, McAdam KP, Pinder M: Plasmodium falciparum infection
of the placenta affects newborn immune responses.  Clin Exp
Immunol 2003, 133:414-421.
10. King CL, Malhotra I, Wamachi A, Kioko J, Mungai P, Wahab SA,
Koech D, Zimmerman P, Ouma J, Kazura JW: Acquired immune
responses to Plasmodium falciparum merozoite surface pro-
tein-1 in the human fetus.  J Immunol 2002, 168:356-364.
11. Brustoski K, Moller U, Kramer M, Petelski A, Brenner S, Palmer DR,
Bongartz M, Kremsner PG, Luty AJ, Krzych U: IFN-gamma and IL-
10 mediate parasite-specific immune responses of cord
blood cells induced by pregnancy-associated Plasmodium fal-
ciparum malaria.  J Immunol 2005, 174:1738-1745.
12. Brustoski K, Moller U, Kramer M, Hartgers FC, Kremsner PG, Krzych
U, Luty AJ: Reduced cord blood immune effector-cell respon-
siveness mediated by CD4+ cells induced in utero as a conse-
quence of placental Plasmodium falciparum infection.  J Infect
Dis 2006, 193:146-154.
13. Wykes MN, Good MF: What really happens to dendritic cells
during malaria?  Nat Rev Microbiol 2008, 6:864-870.
14. Wykes MN, Liu XQ, Beattie L, Stanisic DI, Stacey KJ, Smyth MJ, Tho-
mas R, Good MF: Plasmodium strain determines dendritic cell
function essential for survival from malaria.  PLoS Pathog 2007,
3:e96.
15. Belkaid Y, Rouse BT: Natural regulatory T cells in infectious
disease.  Nat Immunol 2005, 6:353-360.
16. Lindstedt M, Lundberg K, Borrebaeck CA: Gene family clustering
identifies functionally associated subsets of human in vivo
blood and tonsillar dendritic cells.  J Immunol 2005,
175:4839-4846.
17. Piccioli D, Tavarini S, Borgogni E, Steri V, Nuti S, Sammicheli C,
Bardelli M, Montagna D, Locatelli F, Wack A: Functional speciali-
zation of human circulating CD16 and CD1c myeloid den-
dritic-cell subsets.  Blood 2007, 109:5371-5379.
18. Levy O: Innate immunity of the newborn: basic mechanisms
and clinical correlates.  Nat Rev Immunol 2007, 7:379-390.
19. Adkins B, Jones M, Bu Y, Levy RB: Neonatal tolerance revisited
again: specific CTL priming in mouse neonates exposed to
small numbers of semi- or fully allogeneic spleen cells.  Eur J
Immunol 2004, 34:1901-1909.
Additional file 1
Presence of P. falciparum parasite in maternal and/or placental 
blood at delivery does not influence the activation status of cord blood 
DC and monocytes. The expression levels of HLA-DR and CD86 were 
measured by flow cytometry on foetal APC from 27 P. falciparum-positive 
(diagonal striped bars) and 28 P. falciparum-negative mothers (white 
bars).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-
2875-8-251-S1.pdf]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2009, 8:251 http://www.malariajournal.com/content/8/1/251
Page 12 of 12
(page number not for citation purposes)
20. Eijnden S Vanden, Goriely S, De Wit D, Goldman M, Willems F: Pref-
erential production of the IL-12(p40)/IL-23(p19) het-
erodimer by dendritic cells from human newborns.  Eur J
Immunol 2006, 36:21-26.
21. Encabo A, Solves P, Carbonell-Uberos F, Minana MD: The func-
tional immaturity of dendritic cells can be relevant to
increased tolerance associated with cord blood transplanta-
tion.  Transfusion 2007, 47:272-279.
22. Adegnika AA, Kohler C, Agnandji ST, Chai SK, Labuda L, Breitling LP,
Schonkeren D, Weerdenburg E, Issifou S, Luty AJ, Kremsner PG,
Yazdanbakhsh M: Pregnancy-Associated Malaria Affects Toll-
Like Receptor Ligand-Induced Cytokine Responses in Cord
Blood.  J Infect Dis 2008, 198:928-936.
23. Breitling LP, Fendel R, Mordmueller B, Adegnika AA, Kremsner PG,
Luty AJ: Cord blood dendritic cell subsets in African newborns
exposed to Plasmodium falciparum in utero.  Infect Immun 2006,
74:5725-5729.
24. Diallo M, Aldebert D, Moreau JC, Ndiaye M, Jambou R: Decrease of
lymphoid dendritic cells in blood frommalaria-infected preg-
nant women.  Int J Parasitol 2008 in press.
25. Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas
ZK, Endres S, Krieg AM, Hartmann G: Identification of CpG oli-
gonucleotide sequences with high induction of IFN-alpha/
beta in plasmacytoid dendritic cells.  Eur J Immunol 2001,
31:2154-2163.
26. Egan TJ: Structure-function relationships in chloroquine and
related 4-aminoquinoline antimalarials.  Mini Rev Med Chem
2001, 1:113-123.
27. Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, Visintin A, Hal-
men KA, Lamphier M, Olivier M, Bartholomeu DC, Gazzinelli RT,
Golenbock DT: Malaria hemozoin is immunologically inert but
radically enhances innate responses by presenting malaria
DNA to Toll-like receptor 9.  P r o c  N a t l  A c a d  S c i  U S A  2007,
104:1919-1924.
28. Jakobsen PH, Rasheed FN, Bulmer JN, Theisen M, Ridley RG, Green-
wood BM: Inflammatory reactions in placental blood of Plas-
modium falciparum- infected women and high concentrations
of soluble E-selectin and a circulating P. falciparum protein in
the cord sera.  Immunology 1998, 93:264-269.
29. Briand V, Denoeud L, Massougbodji A, Cot M: Efficacy of intermit-
tent preventive treatment versus chloroquine prophylaxis to
prevent malaria during pregnancy in Benin.  J Infect Dis 2008,
198:594-601.
30. Millington OR, Gibson VB, Rush CM, Zinselmeyer BH, Phillips RS,
Garside P, Brewer JM: Malaria impairs T cell clustering and
immune priming despite normal signal 1 from dendritic
cells.  PLoS Pathog 2007, 3:1380-1387.
31. Bhattacharyya S, Cowan MJ: B7.2-/- mature dendritic cells gen-
erate T-helper 2 and regulatory T donor cells in fetal mice
after in utero allogeneic bone marrow transplantation.  Biol
Blood Marrow Transplant 2005, 11:657-671.
32. Hochweller K, Anderton SM: Kinetics of costimulatory molecule
expression by T cells and dendritic cells during the induction
of tolerance versus immunity in vivo.  Eur J Immunol 2005,
35:1086-1096.
33. Schultze J, Nadler LM, Gribben JG: B7-mediated costimulation
and the immune response.  Blood Rev 1996, 10:111-127.
34. Schwartz RH: A cell culture model for T lymphocyte clonal
anergy.  Science 1990, 248:1349-1356.
35. Urban BC, Cordery D, Shafi MJ, Bull PC, Newbold CI, Williams TN,
Marsh K: The frequency of BDCA3-positive dendritic cells is
increased in the peripheral circulation of Kenyan children
with severe malaria.  Infect Immun 2006, 74:6700-6706.
36. Urban BC, Mwangi T, Ross A, Kinyanjui S, Mosobo M, Kai O, Lowe B,
Marsh K, Roberts DJ: Peripheral blood dendritic cells in chil-
dren with acute Plasmodium falciparum malaria.  Blood 2001,
98:2859-2861.
37. Urban BC, Ferguson DJ, Pain A, Willcox N, Plebanski M, Austyn JM,
Roberts DJ: Plasmodium falciparum-infected erythrocytes
modulate the maturation of dendritic cells.  Nature 1999,
400:73-77.
38. Broen K, Brustoski K, Engelmann I, Luty AJ: Placental Plasmodium
falciparum infection: causes and consequences of in utero sen-
sitization to parasite antigens.  Mol Biochem Parasitol 2007,
151:1-8.
39. Barchet W, Wimmenauer V, Schlee M, Hartmann G: Accessing the
therapeutic potential of immunostimulatory nucleic acids.
Curr Opin Immunol 2008, 20:389-395.
40. Gursel M, Gursel I, Mostowski HS, Klinman DM: CXCL16 influ-
ences the nature and specificity of CpG-induced immune
activation.  J Immunol 2006, 177:1575-1580.
41. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, Yamamoto
M, Takeuchi O, Itagaki S, Kumar N, et al.: Toll-like receptor 9
mediates innate immune activation by the malaria pigment
hemozoin.  J Exp Med 2005, 201:19-25.
42. Pichyangkul S, Yongvanitchit K, Kum-arb U, Hemmi H, Akira S, Krieg
AM, Heppner DG, Stewart VA, Hasegawa H, Looareesuwan S, Shanks
GD, Miller RS: Malaria blood stage parasites activate human
plasmacytoid dendritic cells and murine dendritic cells
through a Toll-like receptor 9-dependent pathway.  J Immunol
2004, 172:4926-4933.
43. Hanscheid T, Egan TJ, Grobusch MP: Haemozoin: from mela-
tonin pigment to drug target, diagnostic tool, and immune
modulator.  Lancet Infect Dis 2007, 7:675-685.
44. Diouf I, Fievet N, Doucoure S, Ngom M, Andrieu M, Mathieu JF, Gaye
A, Thiaw OT, Deloron P: IL-12 producing monocytes and IFN-
gamma and TNF-alpha producing T-lymphocytes are
increased in placentas infected by Plasmodium falciparum.  J
Reprod Immunol 2007, 74:152-162.
45. McGuckin CP, Basford C, Hanger K, Habibollah S, Forraz N: Cord
blood revelations: the importance of being a first born girl,
big, on time and to a young mother!  Early Hum Dev 2007,
83:733-741.
46. Lutz MB, Schuler G: Immature, semi-mature and fully mature
dendritic cells: which signals induce tolerance or immunity?
Trends Immunol 2002, 23:445-449.
47. De Wit D, Olislagers V, Goriely S, Vermeulen F, Wagner H, Goldman
M, Willems F: Blood plasmacytoid dendritic cell responses to
CpG oligodeoxynucleotides are impaired in human new-
borns.  Blood 2004, 103:1030-1032.
48. Wynn JL, Neu J, Moldawer LL, Levy O: Potential of immunomod-
ulatory agents for prevention and treatment of neonatal sep-
sis.  J Perinatol 2009, 29(2):79-88.